HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James L Boyer Selected Research

Bilirubin

1/2018Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
10/2010Role of breast cancer resistance protein in the adaptive response to cholestasis.
5/2007Nuclear receptors RXRalpha:RARalpha are repressors for human MRP3 expression.
11/2005Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis.
1/2003Molecular characterization of a multidrug resistance-associated protein, Mrp2, from the little skate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James L Boyer Research Topics

Disease

36Cholestasis
01/2023 - 08/2002
14Liver Diseases (Liver Disease)
10/2023 - 05/2002
13Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2023 - 05/2003
12Inflammation (Inflammations)
01/2023 - 02/2011
11Sclerosing Cholangitis
10/2023 - 05/2003
9Fibrosis (Cirrhosis)
01/2022 - 08/2005
6Liver Cirrhosis (Hepatic Cirrhosis)
04/2021 - 02/2011
6Necrosis
01/2018 - 08/2005
5progressive familial intrahepatic 1 Cholestasis
11/2021 - 10/2002
4Autoimmune Hepatitis
05/2022 - 08/2005
4Neoplasms (Cancer)
01/2019 - 11/2005
2Non-alcoholic Fatty Liver Disease
01/2022 - 03/2015
2COVID-19
01/2022 - 01/2021
2Liver Failure
12/2021 - 08/2015
2Intrahepatic Cholestasis
11/2021 - 05/2010
2Body Weight (Weight, Body)
01/2018 - 02/2011
2Insulin Resistance
03/2015 - 03/2014
2Weight Gain
03/2014 - 08/2005
2Brain Diseases (Brain Disorder)
11/2005 - 08/2005
2Ascites
11/2005 - 08/2005
2Hemorrhage
11/2005 - 08/2005
1Disease Progression
10/2023
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1Hematologic Neoplasms (Hematological Malignancy)
01/2019
1Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2019
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2019
1Hepatocellular Carcinoma (Hepatoma)
11/2018
1Autoimmune Diseases (Autoimmune Disease)
12/2016
1Obesity
03/2015
1Metabolic Syndrome (Dysmetabolic Syndrome X)
03/2015
1Gaucher Disease (Gaucher's Disease)
04/2014

Drug/Important Bio-Agent (IBA)

28Bile Acids and Salts (Bile Acids)IBA
01/2023 - 05/2002
11CytokinesIBA
12/2022 - 08/2002
8Proteins (Proteins, Gene)FDA Link
01/2021 - 04/2004
6Ursodeoxycholic Acid (Urso)FDA LinkGeneric
12/2021 - 05/2002
5Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2018 - 08/2010
5BilirubinIBA
01/2018 - 01/2003
4Fenofibrate (CiL)FDA LinkGeneric
12/2022 - 03/2014
4Member 11 Subfamily B ATP Binding Cassette TransporterIBA
11/2021 - 10/2002
4Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
08/2015 - 08/2002
3Cholic AcidIBA
01/2023 - 12/2016
3Fibric Acids (Fibrates)IBA
12/2022 - 05/2013
3LipidsIBA
01/2022 - 05/2010
3Multidrug Resistance-Associated ProteinsIBA
01/2014 - 04/2004
2Hydroxyproline (4 Hydroxyproline)IBA
01/2020 - 04/2014
2Messenger RNA (mRNA)IBA
11/2018 - 06/2006
2EnzymesIBA
01/2018 - 01/2014
2Macrophage Migration-Inhibitory FactorsIBA
12/2016 - 02/2014
2Glucose (Dextrose)FDA LinkGeneric
03/2014 - 05/2010
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
05/2012 - 09/2003
2Adenosine Triphosphate (ATP)IBA
05/2012 - 10/2010
2LigandsIBA
08/2005 - 05/2004
2Carrier Proteins (Binding Protein)IBA
04/2003 - 08/2002
1CateninsIBA
01/2023
1Dual OxidasesIBA
01/2023
1PPAR alphaIBA
12/2022
1GlucocorticoidsIBA
01/2022
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
01/2022
1Tacrolimus (Prograf)FDA LinkGeneric
01/2022
1Oxygen (Dioxygen)IBA
01/2022
1Triglycerides (Triacylglycerol)IBA
01/2022
1Alkaline PhosphataseIBA
12/2021
1Semaphorins (Semaphorin)IBA
11/2021
1Alanine (L-Alanine)FDA Link
01/2021
1Antiviral Agents (Antivirals)IBA
01/2021
1InflammasomesIBA
01/2020
1Immunoconjugates (Immunoconjugate)IBA
01/2019
1AntigensIBA
01/2019
1Inotuzumab OzogamicinIBA
01/2019
1Dinoprostone (PGE2)FDA Link
11/2018
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
11/2018
1Keratin-19 (Keratin 19)IBA
11/2018
1Organic Anion TransportersIBA
11/2018
1Thyroxine (Levothyroxine)FDA LinkGeneric
11/2018
1Therapeutic UsesIBA
01/2018
1Sirtuin 1IBA
12/2016
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
12/2015
1ezrinIBA
12/2015
1radixinIBA
12/2015
1lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
12/2015
1sodium-hydrogen exchanger regulatory factorIBA
10/2015
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
10/2015
1Methionine (L-Methionine)FDA Link
03/2015
1Transaminases (Aminotransferases)IBA
03/2015
12,4-Dinitrophenol (2,4 Dinitrophenol)IBA
03/2015
1Choline (Choline Chloride)IBA
03/2015
1Glucosylceramides (Glucocerebrosides)IBA
04/2014
1SphingolipidsIBA
04/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
04/2014
1sphingosyl beta-glucosideIBA
04/2014
1Glucosylceramidase (Glucocerebrosidase)IBA
04/2014
1CollagenIBA
04/2014
1Glutathione (Reduced Glutathione)IBA
01/2014

Therapy/Procedure

15Therapeutics
10/2023 - 08/2005
8Ligation
01/2023 - 09/2003
3Liver Transplantation
08/2015 - 08/2005
2Drug Therapy (Chemotherapy)
12/2022 - 01/2019
2Artificial Respiration (Mechanical Ventilation)
01/2022 - 01/2021
1Cannula
01/2022
1Critical Care (Surgical Intensive Care)
01/2021